2007Journal of Medical ForumRequires access

Effect of Probiotics Drug in Treatment of Mild and Moderate Ulcerative Colitis

Liu Zhan-ju

Open publisher page 1 citations

Abstract

Objective To observe the clinical effects of probiotics drug in the treatment of mild and moderate ulcerative colitis.Methods Total 129 patients with mild to moderate active ulcerative colitis were divided into treatment group (65 patients) and control group (64 patients) at first stage.the former were treated with probiotics drug, the later were treated with mesalazine. the study lasted for 12 weeks and patients were assessed by clinical remission rate and the time to clinical remission.At second stage 91 patients in remission of ulcerative colitis were radomized into two groups to receive probiotics drug (43 patients in treatment group ) or mesalazine (48 patients in control group).After 12 months relapse-free time and relapse rate were determined.Results At first stage,after 12 weeks treatment there were no statistical differences(P0.05)between treatment group and control group in clinical remission rate and the time to clinical remission.At second stage, there were no differences between two groups(P0.05)in relapse-free time and relapse rate.Conclusion Probiotics drug are effective in treatment of mild and moderate active ulcerative colitis and preventing relapse.

About this research paper

What this paper is about

Objective To observe the clinical effects of probiotics drug in the treatment of mild and moderate ulcerative colitis.Methods Total 129 patients with mild to moderate active ulcerative colitis were divided into treatment group (65 patients) and control group (64 patients) at first stage.the former were treated with probiotics drug, the later were treated with mesalazine. the study lasted for 12 weeks and patients were assessed by clinical remission rate and the time to clinical remission.At second stage 91 patients in remission of ulcerative colitis were radomized into two groups to receive probiotics drug (43 patients in treatment group ) or mesalazine (48 patients in control group).After 12 months relapse-free time and relapse rate were determined.Results At first stage,after 12 weeks treatment there were no statistical differences(P0.05)between treatment group and control group in clinical remission rate and the time to clinical remission.At second stage, there were no differences between two groups(P0.05)in relapse-free time and relapse rate.Conclusion Probiotics drug are effective in treatment of mild and moderate active ulcerative colitis and preventing relapse.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinical effects of probiotics drug in the treatment of mild and moderate ulcerative colitis.Methods Total 129 patients with mild to moderate active ulcerative colitis were divided into treatment group (65 patients) and control group (64 patients) at first stage.the former were treated with probiotics drug, the later were treated with mesalazine. the study lasted for 12 weeks and patients were assessed by clinical remission rate and the time to clinical remission.At second stage 91 patients in remission of ulcerative colitis were radomized into two groups to receive probiotics drug (43 patients in treatment group ) or mesalazine (48 patients in control group).After 12 months relapse-free time and relapse rate were determined.Results At first stage,after 12 weeks treatment there were no statistical differences(P0.05)between treatment group and control group in clinical remission rate and the time to clinical remission.At second stage, there were no differences between two groups(P0.05)in relapse-free time and relapse rate.Conclusion Probiotics drug are effective in treatment of mild and moderate active ulcerative colitis and preventing relapse.

Key concepts: Ulcerative colitis, Mesalazine, Medicine, Internal medicine, Gastroenterology, Drug, Stage (stratigraphy), Colitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of Probiotics Drug in Treatment of Mild and Moderate Ulcerative Colitis — Research Paper | ScholarLens